NDRA — ENDRA Life Sciences Share News
0.000.00%
Last trade - 00:00Brief: Endra Life Sciences Announces Closing Of Public Offering
Endra Life Sciences slips on stock offering, loss forecast
Brief: Endra Life Sciences Inc Says Expects No Revenue For Quarter Ended March 31, 2023
Brief: Endra Life Sciences Inc Files For Offering Of 3 Million Shares Of Common Stock, Warrants To Purchase Up To 1.5 Million Shares Of Common Stock - SEC Filing
U.S. RESEARCH ROUNDUP- Enliven Therapeutics, Lululemon Athletica, Walgreens
Brief: Endra Life Sciences Inc - Net Loss In The Fourth Quarter Of 2022 Was $3.3 Million, Or $1.04 Per Share
Endra Life Sciences Inc Reports Results For The Quarter Ended In December: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 90 Cents A Share: Earnings Preview
Brief: ENDRA Life Sciences Enters Into Amendment 5 With General Electric
Brief: Endra Life Sciences Announces 1-For-20 Reverse Stock Split
Brief: Endra Life Sciences Approves A Reverse Stock Split Ratio Of 1-For-20
U.S. RESEARCH ROUNDUP-Freshworks, PowerSchool Holdings, Upland Software
Endra Life Sciences Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: ENDRA Life Sciences Reports Third Quarter 2022 Financial Results
Endra Life Sciences Inc Expected To Post A Loss Of 5 Cents A Share: Earnings Preview
Brief: ENDRA Life Sciences Enhances Taeus System Intellectual Property Portfolio With Issuance Of Two U.S. Patents
Brief: Endra Life Sciences Plans To Submit De Novo Request To U.S. FDA For Its Taeus® System In Coming Weeks
U.S. RESEARCH ROUNDUP-Alignment Healthcare, Comerica, M&T Bank Corp
Brief: Endra Life Sciences Announces Issuance Of 8Th European Patent For Its Taeus System